Embla Medical hf Future Growth
Future criteria checks 2/6
Embla Medical hf is forecast to grow earnings and revenue by 17.4% and 8.3% per annum respectively. EPS is expected to grow by 17.1% per annum. Return on equity is forecast to be 10.6% in 3 years.
Key information
17.4%
Earnings growth rate
17.1%
EPS growth rate
| Medical Equipment earnings growth | 19.9% |
| Revenue growth rate | 8.3% |
| Future return on equity | 10.6% |
| Analyst coverage | Low |
| Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?
Jan 26Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain
Jan 08
We're Watching These Trends At Össur hf (CPH:OSSR)
Dec 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,018 | 103 | 111 | 151 | 4 |
| 12/31/2025 | 945 | 87 | 98 | 136 | 5 |
| 12/31/2024 | 869 | 72 | 30 | 107 | 4 |
| 3/31/2024 | 804 | 57 | 47 | 93 | N/A |
| 12/31/2023 | 786 | 58 | 52 | 94 | N/A |
| 9/30/2023 | 766 | 52 | 43 | 82 | N/A |
| 6/30/2023 | 750 | 45 | 37 | 72 | N/A |
| 3/31/2023 | 730 | 43 | 28 | 57 | N/A |
| 12/31/2022 | 719 | 43 | 35 | 61 | N/A |
| 9/30/2022 | 715 | 47 | 49 | 76 | N/A |
| 6/30/2022 | 719 | 57 | 50 | 79 | N/A |
| 3/31/2022 | 728 | 62 | 69 | 96 | N/A |
| 12/31/2021 | 719 | 64 | 74 | 101 | N/A |
| 9/30/2021 | 701 | 50 | 54 | 77 | N/A |
| 6/30/2021 | 692 | 48 | 63 | 84 | N/A |
| 3/31/2021 | 637 | 11 | 62 | 82 | N/A |
| 12/31/2020 | 630 | 6 | 68 | 92 | N/A |
| 9/30/2020 | 639 | 20 | 65 | 92 | N/A |
| 6/30/2020 | 635 | 19 | 78 | 109 | N/A |
| 3/31/2020 | 680 | 59 | 75 | 109 | N/A |
| 12/31/2019 | 686 | 66 | 63 | 95 | N/A |
| 9/30/2019 | 675 | 83 | 72 | 102 | N/A |
| 6/30/2019 | 652 | 85 | 55 | 84 | N/A |
| 3/31/2019 | 631 | 83 | 47 | 76 | N/A |
| 12/31/2018 | 613 | 80 | 39 | 69 | N/A |
| 9/30/2018 | 599 | 69 | 48 | 78 | N/A |
| 6/30/2018 | 593 | 64 | 44 | 71 | N/A |
| 3/31/2018 | 579 | 58 | 48 | 72 | N/A |
| 12/31/2017 | 569 | 58 | N/A | 74 | N/A |
| 9/30/2017 | 553 | 49 | N/A | 64 | N/A |
| 6/30/2017 | 543 | 51 | N/A | 68 | N/A |
| 3/31/2017 | 538 | 52 | N/A | 61 | N/A |
| 12/31/2016 | 521 | 51 | N/A | 66 | N/A |
| 9/30/2016 | 507 | 49 | N/A | 69 | N/A |
| 6/30/2016 | 495 | 50 | N/A | 65 | N/A |
| 3/31/2016 | 483 | 51 | N/A | 74 | N/A |
| 12/31/2015 | 483 | 51 | N/A | 66 | N/A |
| 9/30/2015 | 488 | 54 | N/A | 67 | N/A |
| 6/30/2015 | 497 | 55 | N/A | 77 | N/A |
| 3/31/2015 | 502 | 57 | N/A | 79 | N/A |
| 12/31/2014 | 509 | 59 | N/A | 85 | N/A |
| 9/30/2014 | 509 | 58 | N/A | 86 | N/A |
| 6/30/2014 | 487 | 55 | N/A | 82 | N/A |
| 3/31/2014 | 460 | 46 | N/A | 71 | N/A |
| 12/31/2013 | 436 | 40 | N/A | 66 | N/A |
| 9/30/2013 | 406 | 35 | N/A | 59 | N/A |
| 6/30/2013 | 400 | 33 | N/A | 49 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EMBLA's forecast earnings growth (17.4% per year) is above the savings rate (0.9%).
Earnings vs Market: EMBLA's earnings (17.4% per year) are forecast to grow faster than the Danish market (13.2% per year).
High Growth Earnings: EMBLA's earnings are forecast to grow, but not significantly.
Revenue vs Market: EMBLA's revenue (8.3% per year) is forecast to grow slower than the Danish market (11.1% per year).
High Growth Revenue: EMBLA's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EMBLA's Return on Equity is forecast to be low in 3 years time (10.6%).